Fitch's 2026 medians put the nonprofit hospital operating margin at 1.5% on audited FY2025 financials, up from 1.1%. Personnel expense fell 90 basis points as a share of operating revenue over the same period-meaning the entire margin gain, and then some, came out of the labor line. Fitch calls FY2025 a brief operational peak. Here is what that sequence implies for FY2027 modeling.
The median nonprofit hospital operating margin rose to 1.5% in fiscal 2025 from 1.1% in fiscal 2024, across the 222 organizations in Fitch Ratings' rated portfolio. That is the headline in Fitch's 2026 medians, released this month on audited FY2025 financial statements.
The headline is not the number to model against. This one is: personnel costs fell to 52.6% of total operating revenues from 53.5%. Ninety basis points off the largest expense line, against forty basis points of margin improvement. Medians across a portfolio do not decompose arithmetically-the organization at the median on personnel expense is not necessarily the organization at the median on operating margin-but the directional read is hard to escape. The labor line gave up more than the bottom line gained. Whatever else moved in FY2025, it moved against you.
That is the structural fact underneath Fitch's framing, and Fitch is not soft about the framing. Senior Director Kevin Holloran, who heads the nonprofit hospital sector at the agency, tied the improvement to near-record balance sheet metrics and continued volume growth while flagging that "notable divergence across rating categories and the passage of H.R. 1 raise concerns that fiscal 2025 may represent a brief operational peak before conditions become more challenging." The report itself goes further: "Fiscal 2027 and beyond may mark the end of the current recovery arc for many providers."
Sixty-seven percent of Fitch's rated portfolio posted a positive operating margin in FY2025, up from 64% in FY2024 and 50% in FY2022. Read alone, that is a sector healing. Read against the range, it is a sector splitting: operating margins across the portfolio ran from 34.4% at the top to negative 17.3% at the bottom, and the below-investment-grade cohort's median operating margin deteriorated to -2.8% from +1.6%-a 440 basis point reversal in the same year the overall median improved 40.
That is the whole story in two numbers. The median moved up because the top of the distribution moved up. Fitch is explicit that the balance sheet gains are "almost entirely a top-tier phenomenon" and that lower-rated organizations experienced declines.
The balance sheet metrics tell the same story from the asset side. Median days cash on hand was effectively flat at 212, down three days from 215. Median cash to debt hit a record 188.0%, up from 169.2%. Debt to capitalization fell to a historical low of 28.9% from roughly 31%. And median capital spending reached a 17-year high at 142.7% of depreciation expense-organizations are reinvesting well above replacement rate.
If you are a CFO at an A-category system, that combination is a green light: cheap leverage capacity, record liquidity coverage, and a mandate to spend into it. If you are running a BBB- or below credit with meaningful Medicaid exposure, the same medians describe a market where your competitors are recapitalizing plant and equipment while your operating margin goes negative. The M&A implication is not subtle, and Fitch says so directly, predicting accelerating consolidation as "providers will increasingly pool resources, develop joint strategies and pursue affiliation models that provide balance sheet reinforcement and operational scale."
A margin recovery built on expense discipline has a floor and a revenue recovery does not. That is the modeling distinction that matters going into FY2027.
The FY2025 personnel improvement came substantially from the normalization of pandemic-era labor stressors-contract labor rolling off, premium pay compressing, vacancy rates settling. Those are one-time reversions, not a durable operating advantage, and the reversion is largely complete. Fitch credits the year's gains to that resolution, to generally strong patient volumes, and to what it calls "proactive management intervention" ahead of OBBBA-reorganizations and technology deployments undertaken specifically in anticipation of what is coming. That last category is a CFO pulling forward every available cost action into the year before the revenue hit. It works once.
Meanwhile the revenue side is scheduled. CMS finalized the FY2027 IPPS rule on July 31, 2026, with a +2.3% operating payment update-a projected 3.2% market basket increase reduced by a 0.9 percentage point productivity adjustment-and an estimated $2.1 billion aggregate increase in hospital payments, plus roughly $779 million in additional new-technology add-on payments. Rates take effect October 1, 2026.
Sit those two numbers next to each other. Your personnel line gave you 90 basis points in FY2025. CMS's productivity adjustment is taking 90 basis points off your FY2027 market basket. The federal payment update is engineered to capture precisely the kind of efficiency gain the medians just recorded, and it does so every year, whether or not you can produce another one.
The OBBBA Medicaid provisions Fitch is pointing at-enrollment reductions, work requirements, more frequent and more demanding eligibility recertifications, caps on provider taxes and on state-directed payments-are, in Fitch's characterization, "expected to become meaningfully effective beginning in 2027."
The provider tax and state-directed payment caps deserve separate modeling from the coverage provisions, because they hit different lines. Coverage loss shows up as payer-mix deterioration and bad debt-self-pay and uncompensated care growth as Medicaid enrollees churn off. Provider tax and SDP limits hit supplemental payment revenue directly, and for systems where those programs are load-bearing, that is a step function rather than a drift.
And the leading indicator is already showing. Fitch notes that year-to-date benchmarks suggest 2026 operating margins are lagging 2025-before any OBBBA Medicaid provision has meaningfully bound.
The sequence Fitch is describing is specific: labor cost normalizes, margins improve modestly, capital spending accelerates into the improvement, and then the revenue side turns. A CFO who reads the 1.5% as a trajectory will build FY2027 off a base that assumes the expense gain repeats. It does not repeat. There is no second contract-labor unwind.
The defensible base case treats FY2025 as the high-water mark for the operating line and asks a narrower question: with personnel already at 52.6% of revenue, where does the next 90 basis points come from when Medicaid revenue steps down and the productivity adjustment keeps taking its cut? For most organizations the honest answer is that it does not come from operations at all-it comes from the balance sheet, from scale, or from exiting service lines.
Which of those three is your board prepared to authorize, and have you asked them yet?
Discover how Addie helps health systems, post-acute providers, and payers improve throughput, reduce avoidable days, and deliver better transitions of care.
Get Started
